Published in Thromb Res on December 03, 2007
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med (2009) 1.63
Social isolation alters neuroinflammatory response to stroke. Proc Natl Acad Sci U S A (2009) 1.34
Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol (2011) 1.21
Cytokines and myelination in the central nervous system. ScientificWorldJournal (2008) 1.04
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance. Curr Neuropharmacol (2012) 0.83
Correlation between proinflammatory serum markers: high sensitivity C-reactive protein, interleukin-6 with disability score in acute ischemic stroke. Indian J Clin Biochem (2011) 0.77
Predictive role of high sensitive C-reactive protein in early onset mortality after ischemic stroke. Iran J Neurol (2012) 0.75
Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra-early thrombolytic therapy. Exp Ther Med (2015) 0.75
Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol (2010) 4.01
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis (2012) 2.38
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull (2006) 2.01
Hyperglycemia and acute ischemic stroke. Isr Med Assoc J (2004) 1.97
Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes. Int J Cardiol (2011) 1.94
Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke (2011) 1.73
Grading carotid stenosis using ultrasonic methods. Stroke (2012) 1.70
Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology (2009) 1.64
Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64
Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63
Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis (2005) 1.60
Ischemic stroke on awakening: patients' characteristics, outcomes and potential for reperfusion therapy. Neuroepidemiology (2012) 1.55
Burnout and risk of type 2 diabetes: a prospective study of apparently healthy employed persons. Psychosom Med (2006) 1.52
Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol (2013) 1.52
Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med (2002) 1.51
Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol (2007) 1.50
Asthma in adventure travelers: a prospective study evaluating the occurrence and risk factors for acute exacerbations. Arch Intern Med (2002) 1.45
Attempted forced titration of blood pressure to <130/85 mm Hg in type 2 diabetic hypertensive patients in clinical practice: the diastolic cost. J Clin Hypertens (Greenwich) (2006) 1.41
Lessons learned from 2 years experience in intravenous thrombolysis for acute ischemic stroke in a single tertiary medical center. Isr Med Assoc J (2009) 1.39
The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol (2005) 1.31
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke (2011) 1.22
Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum (2006) 1.17
On the nature of burnout-insomnia relationships: a prospective study of employed adults. J Psychosom Res (2008) 1.16
Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11
Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10
Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke (2012) 1.09
Revascularization of the right coronary artery in bilateral internal thoracic artery grafting. Ann Thorac Surg (2005) 1.06
Stroke: working toward a prioritized world agenda. Stroke (2010) 1.05
DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke. Stroke (2008) 1.04
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med (2010) 1.04
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. Clin Cardiol (2013) 1.02
Environmental air pollution has decremental effects on pulmonary function test parameters up to one week after exposure. Am J Med Sci (2009) 1.01
Stroke: working toward a prioritized world agenda. Cerebrovasc Dis (2010) 1.01
Burnout and risk of coronary heart disease: a prospective study of 8838 employees. Psychosom Med (2012) 0.97
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics. J Neurol (2012) 0.97
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis (2010) 0.95
The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. Thromb Res (2006) 0.93
Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease. J Mol Neurosci (2013) 0.93
The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol (2010) 0.92
Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism (2009) 0.91
Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma. Eur J Haematol (2007) 0.91
Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization. J Thromb Thrombolysis (2014) 0.90
Assessment of additional endpoints for trials in acute stroke - what, when, where, in who? Int J Stroke (2012) 0.90
Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis (2009) 0.90
Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol (2009) 0.89
Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med (2004) 0.88
Vitamin D deficiency prevalence and cardiovascular risk in Israel. Eur J Clin Invest (2010) 0.88
Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J (2005) 0.88
The effects of physical fitness and feeling vigorous on self-rated health. Health Psychol (2008) 0.87
A new scale for assessing patients with vertebrobasilar stroke-the Israeli Vertebrobasilar Stroke Scale (IVBSS): inter-rater reliability and concurrent validity. Clin Neurol Neurosurg (2007) 0.87
Stroke-in-evolution: infarct-inherent mechanisms versus systemic causes. Cerebrovasc Dis (2005) 0.87
Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke. Cerebrovasc Dis (2012) 0.87
C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis (2010) 0.87
Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. Metabolism (2008) 0.87
Association of components of the metabolic syndrome with the appearance of aggregated red blood cells in the peripheral blood. An unfavorable hemorheological finding. Diabetes Metab Res Rev (2005) 0.87
Effect of tumor necrosis factor-alpha on endothelial and inducible nitric oxide synthase messenger ribonucleic acid expression and nitric oxide synthesis in ischemic and nonischemic isolated rat heart. J Am Coll Cardiol (2003) 0.87
Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost (2013) 0.86
C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin Biochem (2009) 0.86
Predictors for poststroke outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study protocol. Int J Stroke (2011) 0.86
A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol (2003) 0.85
Glycohaemoglobin as a determinant of increased fibrinogen concentrations and low-grade inflammation in apparently healthy nondiabetic individuals. Clin Endocrinol (Oxf) (2007) 0.85
Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol (2003) 0.85
Thrombosis following acute cytomegalovirus infection: a community prospective study. Ann Hematol (2013) 0.85
Long-term outcome poststroke: predictors of activity limitation and participation restriction. Arch Phys Med Rehabil (2011) 0.85
Stroke: working toward a prioritized world agenda. Int J Stroke (2010) 0.84
Leukoaraiosis is a chronic atherosclerotic disease. ScientificWorldJournal (2012) 0.84